Table 4.
Hospital Exemption Products in Germany
| Proprietary Name | Description | Therapeutic Area | Therapeutic Indication | Authorization Holder |
|---|---|---|---|---|
| DCVax-L | autologous antigen-presenting dendritic cells | oncology | various types of solid tumors | Northwest Biotherapeutics |
| CIK-Cells | allogenic human cytokine-activated natural killer like T cells | oncology | various types of solid tumors | German Red Cross, blood donation service in Baden-Wuerttemberg and Hessen |
| BioSeed-C | autologous 3D chondrocytes transplant | tissue repair/regenerative medicine | repair of knee cartilage defects | BioTissue Technologies |
| co.don chondrosphere | autologous, matrix-associated chondrocytes for implantation | tissue repair/regenerative medicine | repair of knee cartilage defects | co.don AG, Teltow |
| Human allogeneic mesenchymal Stromal cells | allogeneic mesenchymal stromal cells | tissue repair/regenerative medicine | repair of various tissue types | German Red Cross, blood donation service in Baden-Wuerttemberg and Hessen |
| MukoCell | autologous oral mucosa cells for surgical repair of urethral strictures | urology | surgical treatment for patients with urethral narrowing | UroTiss Europe |
| NOVOCART 3D | autologous 3D matrix-associated chondrocytes for transplantation | tissue repair/regenerative medicine | repair of articular cartilage defects | TETEC |
| NOVOCART Inject | autologous chondrocytes and hydrogel for in situ polymerization. | tissue repair/regenerative medicine | repair of articular cartilage defects | TETEC |
| t2c001 | autologous bone marrow-derived progenitor cells | tissue repair/regenerative medicine | repair of damaged cardiac tissue in patients with ischemic heart disease or myocardial infarction and tissue repair in patients with peripheral vascular disease | t2cure, Frankfurt |
Date of search: March 7, 2017. Source of information: http://www.pei.de/DE/infos/pu/genehmigungen/atmp-4b-amg/antraege-genehmigung-4b-amg-atmp-node.html.